#vivo

Collection of vivo news, found 47 news.

FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...

Finesse Solutions and Corning Life Sciences Highlight Collaboration at CellWorld2015

- Finesse Solutions, Inc., a leading manufacturer of measurement, single-use and automation solutions for life sciences ...

Johnson & Johnson Innovation - JJDC Makes $15 Million Investment in Vivo Capital Fund

- Johnson & Johnson Innovation - JJDC, Inc. (JJDC) today announced a USD $15 million commitment to Vivo Capital ...

The TransMedics® Organ Care System (OCS®) Heart Technology Was Used to Perform The World's First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincen

- TransMedics announces that its OCS® Heart technology was used to preserve and assess the world's first series of ...

Dr. Rongxiang Xu: Mankind Is Entering New Era of Applied Organ Regeneration Science

- Dr. Rongxiang Xu received the Golden Biatec 2013 International award from the Informal Economic Forum (IEF) Economic ...

Dr. Rongxiang Xu, US Patent Owner of "Damaged Organ Regeneration" Scientific Route Promoted by President Obama, Invents

- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical ...

Article Published in JAMA Dermatology Shows Long-term Effectiveness of Ingenol Mebutate in Treating Actinic Keratosis

-Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 monthsAn analysis of ...

Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...

Telefonica and Microsoft to Deploy New Global Video Platform

- Telefonica Digital and Microsoft Corp. today announced a multiyear strategic agreement to create a new Global Video ...

Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT(R)

-     Five Prime Therapeutics, Inc. ("FivePrime") has entered into research and commercial ...

Polyplus-Transfection Launches the Next Generation PEI Transfection Reagent for Bioproduction

-     PEIpro(TM) further expands an already rich catalogue of innovative ...

Polyplus-transfection Announces the Appointment of ten Additional Biologists and Chemists

-       - Polyplus-transfection celebrates 10 years of commercial growth and research and ...

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

-        - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Polyplus-Transfection and ExcellGene Enter Into A Supply Agreement for PEI-Based Transfection Reagen

-        Polyplus-transfection SA, a privately-held company developing innovative ...